Skip to Content

Medtronic PLC MDT

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

Stewardship

PREMIUM

Medtronic Hit by COVID-19 in Fiscal Fourth Quarter; Holding Steady on Our Fair Value Estimate

Debbie S. Wang Senior Equity Analyst

Analyst Note

| Debbie S. Wang |

Medtronic reported fiscal 2020 fourth-quarter results that underscored the significant impact of the coronavirus pandemic, as roughly half the quarter (from February through April) was hurt by shelter-in-place orders introduced in North America and Europe by mid-March. After making adjustments to our assumptions for tempered results in fiscal 2021, we’re holding steady on our fair value estimate, as timing differences in our discounted cash flow model have only an incremental effect on the cash flows we’ve projected over the next 20 years. Despite the pandemic-driven disruption to normal business, we’ve seen little to suggest that Medtronic’s wide moat--based on intangible assets--is at risk. We expect the relationships with hospital clients that Medtronic has worked to enhance over the past five years--through its arrangements to manage cath labs and electrophysiology outpatient centers, as well as its progress in signing up hospitals for its various risk-based contracts--should benefit the firm as providers seek to resume caring for non-COVID-19 patients and performing the more profitable cardiovascular, neurovascular, and orthopedic procedures that can help stabilize finances at hospitals.

Read Full Analysis

Company Profile

Business Description

One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.

Contact
Lower Hatch Street, 20 On Hatch
Dublin, 2, Ireland
T +353 14381700
Sector Healthcare
Industry Medical Devices
Most Recent Earnings Apr 30, 2020
Fiscal Year End Apr 24, 2021
Stock Type
Employees 90,000

Related